Stock report · Delisted · Nasdaq
Athira Pharma Inc (ATHA)
7.66USD Delisted Final close · Mar 13, 2026
ATHA no longer trades. Athira Pharma Inc was delisted from the Nasdaq in March 2026.
All prices on this page are historical. The last trade was on March 13, 2026, at $7.66.
ATHA stock price history
Final trading statistics
- Final close
- $7.66
- Final trading day
- Mar 13, 2026
- Market cap at delisting
- $30.21M
- Shares outstanding
- 3.94M
- Final 52-week range
- $0.22 – $8.36
- Avg. volume (final 3 mo.)
- 1,090,181
- All-time high
- $343.00 · Dec 2020
- All-time low
- $2.29 · Apr 2025
- Return since IPO
- -95.5%
- Beta
- 2.80
- Book value / share
- $6.79
- Price / book
- 1.13
About Athira Pharma Inc
Athira Pharma, Inc. was a clinical-stage biopharmaceutical company developing small molecules meant to restore nerve cell health and slow neurodegeneration. ATH-1105 for amyotrophic lateral sclerosis and ATH-1020 for neurodegenerative diseases were both in phase 1 trials, and earlier compounds were in preclinical work.
Incorporated in 2011 and based in Bothell, Washington, the company was called M3 Biotechnology, Inc. until April 2019. It was delisted from the Nasdaq in March 2026, with a last trade on March 13, 2026 at $7.66.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Bothell, WA
- Employees
- 26
- IPO date
- September 18, 2020
- Delisted
- March 13, 2026
- SEC CIK
- 1620463
Athira Pharma financials before the delisting
The last 5 fiscal years Athira Pharma reported as a public company, fiscal year ending December.
ATHA revenue and net income
ATHA earnings per share
ATHA annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | — | −$105.6M | — |
| FY2024 | $0.00 | −$96.9M | −$2.53 |
| FY2023 | $0.00 | −$117.7M | −$3.09 |
| FY2022 | $0.00 | −$95.6M | −$2.27 |
| FY2021 | $0.00 | −$54.9M | −$1.50 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Athira Pharma stock FAQ
What happened to Athira Pharma stock?
Athira Pharma Inc was delisted from the Nasdaq in March 2026. The final close was $7.66 on March 13, 2026.
Can I still buy ATHA stock?
No. ATHA is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on March 13, 2026.
What was the last price of ATHA?
ATHA last closed at $7.66 on March 13, 2026, which valued the company at about $30.21M.
How did Athira Pharma do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, Athira Pharma reported revenue of — and net income of −$105.6M.
When did Athira Pharma go public?
Athira Pharma shares started trading on September 18, 2020.
ATHA no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.